Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Amylyx Pharmaceuticals is helping patients follow the clues to uncover the mystery of rare weight-loss surgery complication post-bariatric hypoglycemia (PBH) with the launch of a new patient educat | Amylyx’s patient education website aims to empower patients to navigate post-bariatric hypoglycemia (PBH), a rare and often overlooked complication of weight-loss surgery.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…

Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any…

For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing the first oral…

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor,…

Widespread misconceptions about Type 1 diabetes

As Amgen strives to become the industry’s top player in cardiometabolic risk reduction by the start of the next decade, the…